U.S. Stock News

NYSE:AKR
NYSE:AKRRetail REITs

Is It Too Late To Consider Acadia Realty Trust (AKR) After Its Recent Share Price Rebound?

Investors may be wondering whether Acadia Realty Trust is offering good value at its current price, or if the easier gains have already passed. The stock recently closed at US$20.37, with returns of 4.9% over the last week, a 1.6% decline over the last month, a 1.3% decline year to date, 14.3% over the last year, 74.9% over three years, and 23.6% over five years. Recent coverage has focused on Acadia as a retail focused REIT, with ongoing attention on how its portfolio and tenant mix...
NYSE:WES
NYSE:WESOil and Gas

Is Western Midstream Partners (WES) Still Attractive After Strong 5 Year Price Performance

If you are wondering whether Western Midstream Partners at around US$40.94 is still offering value, you are not alone. This article focuses on exactly that question. The unit price has moved by 2.1% over the last 30 days, with a 25.2% return over 1 year and a very large 217.2% return over 5 years. This naturally raises questions about how much value is already reflected in the current price. Recent news coverage has mainly centered on Western Midstream Partners as a key player in the US...
NYSE:ICE
NYSE:ICECapital Markets

Is It Too Late To Consider Intercontinental Exchange (ICE) After Recent Share Price Strength?

Wondering if Intercontinental Exchange at around US$161.97 is still a fair entry point or if the value story has already played out? This article focuses squarely on what the current price might imply. The stock has moved by 1.1% over the last 30 days and 5.6% over the past year, with a 56.5% return over 3 years and 44.1% over 5 years, which hints at a long track record that many investors will be weighing against today's valuation. Recent coverage has focused on Intercontinental Exchange as...
NYSE:PACS
NYSE:PACSHealthcare

Is It Too Late To Consider PACS Group (PACS) After Its 1-Year Surge?

Investors may be wondering whether PACS Group at around US$35.97 is still offering value after its strong run, or if the easy gains are already behind it. The stock has moved 11.9% over the last 7 days and 5.3% over the last 30 days, while the 1 year return of 286.8% contrasts with a year to date return of a 9.0% decline. Recent attention on PACS Group has centered on its strong 1 year share price performance and the healthcare services segment it operates in. This has made the stock more...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Is It Time To Reassess Tetra Tech (TTEK) After Recent Share Price Weakness

If you are wondering whether Tetra Tech's current share price offers good value or if you might be overpaying for quality, this article walks through the key valuation checks that matter most. The stock last closed at US$30.85, with a 0.7% decline over 7 days, an 8.1% decline over 30 days, and an 8.3% decline year to date. The 1 year, 3 year, and 5 year returns sit at 6.2%, 7.2%, and 16.9% respectively. Recent price movements are occurring against a backdrop of ongoing investor interest in...
NasdaqCM:PROP
NasdaqCM:PROPOil and Gas

Prairie Operating (PROP) Is Down 42.7% After Swinging to Profit and Issuing 2026 Guidance - What's Changed

Prairie Operating Co. reported past full-year 2025 results on March 30, 2026, showing revenue of US$241.65 million versus US$7.94 million a year earlier and moving from a net loss of US$40.91 million to net income of US$32.05 million, alongside detailed production disclosure. Management also issued production and earnings guidance for 2026, targeting average daily output of 25,500–27,500 Boe/d and net income of US$55 million to US$65 million, highlighting how operational scale now ties...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Is Oncolytics Biotech (ONCY) Price Reset Creating A Long Term Opportunity?

Wondering if Oncolytics Biotech at US$1.04 is priced for its potential or already running ahead of itself? This article walks through what the numbers are actually saying about value. The stock shows mixed return figures, with a 7 day return of 8.3%, 30 day return of 2.0%, year to date return of 5.7%, a 1 year return of 108.0%, a 3 year return of 11.9% decline, and a 5 year return of 64.5% decline that some investors may see as a reset in expectations. Recent attention around Oncolytics...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Assessing Omnicell (OMCL) Valuation After Recent Share Price Volatility

Omnicell (OMCL) has been on investors’ radar after recent trading left the shares with a one-month return of about a 9% decline and a past three-month move of roughly a 30% decline. See our latest analysis for Omnicell. At a share price of US$35.47, Omnicell’s 7 day share price return of 3.9% contrasts with a 30 day share price return of about a 9% decline and a year to date share price return of about a 21% decline. The 1 year total shareholder return of 14.1% shows the effect of holding...
NYSE:VSH
NYSE:VSHElectronic

Is It Too Late To Consider Vishay Intertechnology (VSH) After Its 91% One-Year Surge?

If you are wondering whether Vishay Intertechnology at around US$21.33 is still offering value after a strong run, you are not alone. The stock has posted returns of 14.8% over the last week, 23.2% over the last month, 39.5% year to date and 91.2% over the past year. This naturally raises questions about what is already priced in and how much risk you are now taking. Recent coverage has focused on Vishay Intertechnology's position within the broader electronics space and how investors are...
NYSE:SYK
NYSE:SYKMedical Equipment

The Tactical Trio: One AI Imaging Blueprint, One Orthopedic Value Play, One Surgical Compounder

Artificial intelligence in healthcare is attracting fresh attention as investors weigh higher for longer inflation risks, volatile bond yields, and energy driven cost pressures. While many sectors are wrestling with rising input and financing costs, AI in healthcare is focused on accuracy, efficiency, and better patient outcomes, themes that can matter across economic cycles. This article highlights 3 stocks from the Transformative AI Healthcare Stocks screener, a focused way to look at...
NasdaqGS:APLD
NasdaqGS:APLDIT

Applied Digital Q3 Loss Worsens To US$100.9 Million Challenging Margin Expansion Narrative

Applied Digital (APLD) just posted its Q3 2026 numbers, reporting revenue of US$126.6 million and a basic EPS loss of US$0.36. Trailing twelve month revenue came in at US$319.3 million, alongside a basic EPS loss of US$0.46. Over recent quarters, the company’s revenue has moved from US$38.0 million in Q4 2025 to US$64.2 million in Q1 2026, US$161.7 million in Q2 2026 and now US$126.6 million in Q3 2026. Over the same period, quarterly basic EPS shifted from a loss of US$0.12 to a loss of...
NYSE:RSI
NYSE:RSIHospitality

Rush Street Interactive Insider Sales Contrast With Strong Growth And Valuation

Rush Street Interactive (NYSE:RSI) reported recent insider stock sales by its Chief Legal Officer and Chief Financial Officer, carried out under prearranged 10b5-1 trading plans. The insider transactions come as the company continues to report strong fundamental performance, including better-than-expected quarterly results. RSI is also seeing considerable user growth in North American iCasino markets, which remains a key area of focus for the business. Rush Street Interactive operates...
NasdaqGS:QDEL
NasdaqGS:QDELMedical Equipment

QuidelOrtho (QDEL) Is Down 18.0% After Proposed NIH Funding Cuts Raised Diagnostics Demand Questions

A recent proposed 2027 US federal budget outlined sizeable spending cuts for health agencies, including a US$5.00 billion reduction for the National Institutes of Health, raising questions about future research funding across the healthcare ecosystem. For QuidelOrtho, the budget proposal has added another layer of uncertainty to an already pressured diagnostics landscape, where policy decisions can influence funding flows, customer priorities, and long-term demand for testing...
NYSE:ED
NYSE:EDIntegrated Utilities

Can Analyst Optimism Around ED’s Q1 2026 Earnings Signal More Than Just Near‑Term Outperformance?

Consolidated Edison, Inc. has recently drawn attention as analysts grew more optimistic ahead of its 1st Quarter 2026 earnings release, scheduled for May 7, 2026, following a pattern of the company topping earnings estimates in recent quarters. This combination of a positive Earnings ESP and an upgraded Zacks Rank has reinforced the view that Consolidated Edison’s regulated utility operations may continue to surprise relative to consensus expectations. With this backdrop of analyst optimism...
NYSE:MNR
NYSE:MNROil and Gas

Is Mach Natural Resources (MNR) Offering Value After Recent Share Price Weakness?

If you are wondering whether Mach Natural Resources is attractively priced or not, the starting point is understanding what the current share price is actually giving you. The stock recently closed at US$12.35, with a 12.2% decline over the last 7 days and a 5.2% decline over the last 30 days, while still showing a 9.8% return year to date and a 9.3% return over the last year. Recent trading has been shaped by ongoing interest in the oil and gas sector and how investors weigh commodity price...
OTCPK:JDVB
OTCPK:JDVBBanks

JD Bancshares (OTCPK:JDVB) Margin Decline Challenges Bullish Undervaluation Narrative

JD Bancshares (JDVB) just wrapped up FY 2025 with fourth quarter revenue of US$14.6 million and basic EPS of US$0.97, alongside trailing 12 month revenue of US$56.9 million and EPS of US$3.78, compared with FY 2024 trailing 12 month revenue of US$55.6 million and EPS of US$3.97. Over that same trailing 12 month window, net income moved from US$13.6 million in FY 2024 to US$13.0 million in FY 2025. This may prompt investors to focus on how margins and overall profitability quality shape the...
NYSE:STZ
NYSE:STZBeverage

Constellation Brands (STZ) Return To Profitability Tests Bullish Margin Narrative After FY 2026 Results

Constellation Brands (STZ) has just wrapped up FY 2026 with fourth quarter revenue of US$1,920.2 million and basic EPS of US$1.16. The latest trailing twelve month figures show revenue of US$9.1 billion and EPS of US$9.62. Over recent periods, quarterly revenue has ranged from US$1,920.2 million to US$2,515 million, with basic EPS between US$1.16 and US$3.40. This sets up a picture of earnings that now sit against a return to profitability on a trailing basis and margins that investors will...
NYSE:SPB
NYSE:SPBHousehold Products

Is Spectrum Brands Holdings (SPB) Still Attractive After Its Strong 2024 Share Price Run?

If you are wondering whether Spectrum Brands Holdings at about US$80.22 is offering fair value or hiding a margin of safety, you are asking the right question. The stock has delivered returns of 8.8% over the last 7 days, 6.2% over 30 days, 33.6% year to date and 35.2% over the last year, which naturally raises questions about how much of the story is already in the price. Recent coverage around Spectrum Brands Holdings has focused on its role in the Household Products space and how...
NYSE:TFX
NYSE:TFXMedical Equipment

Is Teleflex (TFX) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Teleflex's current share price reflects its true worth, this breakdown will help you see how the market price lines up with several valuation checks. The stock recently closed at US$120.27, with returns of 2.1% over the last week and 7.5% over the last month, while year to date it is down 1.7% and the 1 year return is a 5.7% decline. These mixed returns sit against a backdrop of ongoing attention on Teleflex as a medical equipment company, with investors weighing...
NYSE:LH
NYSE:LHHealthcare

Labcorp Expands Specialized Testing As AI Efficiencies Shape Valuation Story

Labcorp Holdings, NYSE:LH, is expanding into specialized diagnostic testing, including oncology and neurology, through recent acquisitions and product launches. The company is reporting operational improvements and cost savings linked to business optimization and AI driven initiatives. These changes reflect a sharpened focus on higher growth testing segments and more efficient operations. Labcorp Holdings, NYSE:LH, enters this phase of expansion with its shares at $273.26 and a 26.3% return...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

Byrna Technologies (BYRN) Net Margin Drop Challenges Bullish Growth Narratives Ahead Of Q1 2026

Byrna Technologies (BYRN) has just opened its Q1 2026 earnings season narrative following a Q4 2025 print that showed total revenue of US$35.2 million and basic EPS of US$0.15, with trailing twelve month revenue at US$118.1 million and basic EPS of US$0.43. Over recent quarters the company has seen revenue move from US$27.9 million in Q4 2024 to US$35.2 million in Q4 2025, while basic EPS shifted from US$0.43 to US$0.15. This sets up a results story where investors are likely to focus on how...
NasdaqGS:RGP
NasdaqGS:RGPProfessional Services

Resources Connection (RGP) Quarterly Loss Narrows Challenging Bearish Profitability Narratives

Resources Connection (RGP) has reported Q3 2026 revenue of US$107.9 million alongside a basic EPS loss of US$0.28, with trailing 12 month EPS at a loss of US$2.94 on revenue of US$485.2 million. The company has seen quarterly revenue move from US$145.6 million in Q2 2025 to US$129.4 million in Q3 2025 and then to US$107.9 million in Q3 2026. Over the same period, quarterly EPS moved from a loss of US$2.08 in Q2 2025 to a loss of US$1.34 in Q3 2025 and then to a loss of US$0.28 in Q3 2026,...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Is Skyward Specialty Insurance Group (SKWD) Pricing Reflect Its Recent Share Price Slide And Volatility

If you are wondering whether Skyward Specialty Insurance Group at around US$45.89 is offering fair value or a potential bargain, this article will help you put the current share price in context. The stock has risen 4.5% over the last 7 days, while returns sit at a 0.9% decline over 30 days, a 5.6% decline year to date and a 12.0% decline over the past year, compared with a very large 3-year return of 117.7%. Recent coverage has focused on Skyward Specialty Insurance Group's role within the...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Is Kodiak AI (KDK) Pricing Reflect Future Cash Flow Potential After Recent Share Price Slide

Wondering if Kodiak AI at US$7.85 is a bargain or a value trap? This article walks through what the current price could be saying about the stock. The share price has moved 9.0% over the last 7 days, after a 9.5% decline over 30 days and a 27.5% fall year to date, with the 1 year return at 29.7% in the red. Recent coverage has focused on Kodiak AI as part of broader discussions about listed auto related and AI exposed names, with investors weighing business potential against ongoing...